Paradeep Phosphates (PARADEEP) Q4 19/20 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 19/20 earnings summary
2 Nov, 2026Executive summary
FY20 revenue from operations declined to ₹4,192.86 crore from ₹4,357.91 crore; net profit rose to ₹194.05 crore from ₹159.05 crore, supported by lower tax expense.
Manufactured fertilizer production and DAP/NPK sales fell YoY, while traded fertilizer and gypsum sales increased; EBITDA reached ₹494.66 crore versus ₹480.84 crore.
Financial highlights
Revenue from operations was ₹4,192.86 crore versus ₹4,357.91 crore; total income was ₹4,227.78 crore versus ₹4,397.21 crore.
PBT was ₹230.39 crore versus ₹251.49 crore; net profit was ₹194.05 crore versus ₹159.05 crore.
Finance costs rose to ₹191.79 crore from ₹159.25 crore; depreciation and amortization increased to ₹72.48 crore from ₹70.10 crore.
Operating cash flow was ₹1,269.74 crore, versus cash used of ₹920.36 crore in FY19; investing cash outflow was ₹143.16 crore.
Outlook and guidance
Gypsum Pond II was commissioned; a 350 TPD fourth evaporator was under engineering, with completion expected in Dec 2020.
A 400 TPD phosphoric acid plant using Prayon technology was under development; basic engineering was complete.
DAP plant revamp was ~92% complete; D-train revamp was in progress and planned for Aug 2020.
Management assessed COVID-19 effects on liquidity, debt service and asset recoverability as nil at the reporting date, while stating it would continue monitoring impacts.
Latest events from Paradeep Phosphates
- Profit improved as production volumes fell and working-capital needs drove operating cash outflow.PARADEEP
Q4 18/19 - Higher volumes lifted FY22 profit as Goa acquisition and capacity expansion set the growth agenda.PARADEEP
Q4 21/22 - Higher earnings and lower finance costs accompanied a proposed US$280 million Goa acquisition.PARADEEP
Q4 20/21 - Capacity reached 3 MMTPA as revenue surged, while profit and returns fell.PARADEEP
Q4 22/23 - H1 revenue grew, but weaker profits and volumes left debt reduction reliant on Rabi sales.PARADEEP
Q2 26/27 - Revenue up 36% YoY, EBITDA up 25%, with strong DAP sales and MCFL merger boosting growth.PARADEEP
Q1 26/27 - Strong growth in revenue, profit, and volumes, boosted by MCFL merger and expansion projects.PARADEEP
Q3 25/26 - Q1 FY26 revenue up 58% YoY, EBITDA nearly doubled, and MCFL merger nears completion.PARADEEP
Q1 25/26 - Net profit up 134.7% YoY in H1 FY26, driven by MCFL merger and major capacity expansion.PARADEEP
Q2 25/26